Taconic Biosciences News

Taconic Biosciences News is your source for current and relevant news on how animal models are being used to drive drug discovery. Use the links below to explore exciting announcements from Taconic via Press Releases, Taconic’s press coverage in Publications and Media, and critical scientific insights within Industry News.

Taconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska

Rensselaer, NY — April 20, 2018 - Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, has been granted a license to the Easi-CRISPR technology from the University of Nebraska. Easi-CRISPR was developed in the laboratories of Drs. Masato Ohtsuka (Tokai University in Japan), and Channabasavaiah Gurumurthy (University of Nebraska). The terms of the agreement include a world-wide, non-exclusive license to the...

Read More

Taconic Biosciences Launches New Inflammatory Bowel Disease Models

Rensselaer, NY — April 19, 2018 - Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, announces the launch of several new inflammatory bowel disease (IBD) animal models. As a fully-licensed provider of CRISPR/Cas9 gene editing technology, Taconic scientists knocked out the mouse Il10 gene to generate a spontaneous colitis mouse models. The new knockout models were created on Taconic's B6 (C57BL/6NTac)...

Read More

Taconic Biosciences Announces the Formation of Scientific Advisory Board

Rensselaer, NY — February 21, 2018 - Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced the formation of its Scientific Advisory Board (SAB) with the initial appointments of J. Victor Garcia, PhD, Andrew Goodman, PhD, and David Hill, PhD. The SAB will collaborate with Taconic's management in providing scientific insight and guidance on the evolution of the company's product and service...

Read More

Taconic Biosciences has new headquarters

Troy Record speaks with Taconic Biosciences CEO Bob Rosenthal about the rationale behind moving their headquarters: "Community leaders welcomed lab animal company Taconic Biosciences to its new local headquarters on Friday at a ribbon cutting ceremony. Founded in 1949, Taconic Biosciences is a breeder and supplier of laboratory animals, producing selectively bred and genetically engineered mice and rats for research use." Read the complete article at: Troyrecord.co...

Read More

Celebrating new headquarters

Times Union reports on Taconic Biosciences' ribbon cutting ceremony for the new Corporate Headquarters: "The Rensselaer County Regional Chamber of Commerce held a ribbon-cutting ceremony on Friday for Taconic Biosciences at its new headquarters office in the Cancer Research Center building at the University at Albany Health Sciences Campus in East Greenbush. Rensselaer County Executive Steve McLaughlin attended the ceremony along with Taconic CEO Robert J. Rosenthal...

Read More

Generation of Human Immunosuppressive Myeloid Cell Populations in Human Interleukin-6 Transgenic NOG Mice

CIEA's hIL-6 NOG is central in this study which "established a novel humanized transgenic (Tg) mouse strain, human interleukin (hIL)-6-expressing NOG mice (NOG-hIL-6 transgenic mice)." Taconic Biosciences is the only provider of hIL-6 NOG in EU and US: "The tumor microenvironment contains unique immune cells, termed myeloid-derived suppressor cells (MDSCs), and tumor-associated macrophages (TAMs) that suppress host anti-tumor immunity and promote tumor angiogenesis and metastasis. Although these...

Read More

Human immunodeficiency virus Tat impairs mitochondrial fission in neurons

HIV infection is known to cause neurocognitive disorders, with neuronal loss and other abnormalities observed in post-mortem brains of affected individuals. Now a new paper sheds light on the mechanisms of neurotoxicity mediated by the HIV viral protein Tat. Cortical neuronal cultures from embryonic Sprague Dawley® rats sourced from Taconic Biosciences were used as a key model system. The researchers identified that exposure of these rat neuronal...

Read More

Cloned primate paves way for the generation of uniform monkey models, say researchers

Outsourcing Pharma quotes Taconic Biosciences' Michael Seiler, PhD, regarding required factors to establish testable in vivo systems for research: "Biomedical and pharmaceutical stakeholders have heralded the news that Chinese researchers have successfully cloned a monkey and its potential to unlock further our understanding of complex diseases." Read the complete article at: Outsourcing-Pharma.com...

Read More

Industrial Researcher Prize for Research into Improved Animal Models

"Randi Lundberg has received Innovation Fund Denmark's Industrial Researcher Prize for her research into optimising test mice as model organisms for research into the human intestinal flora:" "Each year Innovation Fund Denmark honours the most talented industrial PhDs or postdocs from the fund's talent programme, who have succeeded in combining a high level of scientific insight with a strong business understanding and have generated commercial results for...

Read More

BeHEARD: rewarding rare disease research

Previous BeHEARD competition winner, Jill Wood, discusses the knockout mouse she won from Taconic Biosciences, which lead to the research of future treatments for Sanfilippo syndrome: "In October 2017, the Rare Genomics Institute (RG) announced the launch of the 2018 BeHEARD (Helping Empower and Accelerate Research Discoveries) science challenge. The competition, which has been hosted annually since 2012, aims to advance rare disease research via cash and...

Read More